Enzon Pharmaceuticals Inc (NASDAQ:ENZN)

CAPS Rating: 3 out of 5

A biopharmaceutical company dedicated to the development and commercialization of therapeutics to treat patients with cancer and adjacent diseases.

Results 1 - 16 of 16

Recs

0
Member Avatar mrsteelhead (64.30) Submitted: 7/20/2015 4:37:40 PM : Outperform Start Price: $1.02 ENZN Score: +6.31

its bad ass.

Recs

2
Member Avatar superstar (99.63) Submitted: 4/22/2015 10:49:28 PM : Outperform Start Price: $1.15 ENZN Score: -5.04

ENZN is setting up to skyrocket, Carl Ichan holds over 50 million in stock, it has a nice royalty stream on seven different products, no debt, and pays a nice dividend on occasion. If sold in pieces, the valuation of the company is well above current valuation levels, conservatively near $5 a share. However, it's an interesting company, and management may find it in the best interest of shareholders to search for new revenue streams with its proprietary PEGylation platform, especially, PEGINTRON which is already being used as adjuvant treatment for melanoma. I suspect if it works in treating melanoma, it will be viable in other oncology applications.

Recs

2
Member Avatar jschinagle (< 20) Submitted: 5/13/2013 4:26:19 PM : Underperform Start Price: $0.74 ENZN Score: -18.03

nothing left after large liquidating dividend

Recs

0
Member Avatar Hotpicks101 (29.33) Submitted: 1/21/2011 6:11:35 PM : Outperform Start Price: $1.97 ENZN Score: -99.58

Klarman. Cheap.

Recs

0
Member Avatar jsgant13 (99.28) Submitted: 9/13/2010 1:01:00 PM : Outperform Start Price: $1.86 ENZN Score: -118.07

baupost, deej and value

Recs

0
Member Avatar NoIcons (< 20) Submitted: 2/28/2010 6:33:42 PM : Outperform Start Price: $1.60 ENZN Score: -110.88

outperform

Recs

0
Member Avatar healthcare1 (< 20) Submitted: 1/17/2009 5:04:27 AM : Outperform Start Price: $1.06 ENZN Score: -138.74

it has a unique drug delivery system and activist shareholders

Recs

0
Member Avatar mjan706 (68.60) Submitted: 9/22/2008 1:44:10 AM : Outperform Start Price: $1.34 ENZN Score: -84.37

An Icahn portfolio stock.

Recs

0
Member Avatar hennessy7 (66.25) Submitted: 5/26/2008 9:12:50 AM : Outperform Start Price: $1.51 ENZN Score: -78.77

I like the sector. This is a sector pick as I have done little DD on this stock. I think small biotech has been hit hard, and the cancer market, in particular, is going to turn around. Plus, I do not see too many incredible investments in other sectors so I am sticking to high risk/ high reward opportunities.

Recs

0
Member Avatar WonderWolf (69.76) Submitted: 5/20/2008 11:48:35 PM : Outperform Start Price: $1.51 ENZN Score: -74.88

Working on 2 cancer drugs and will be the big winner!!

Recs

0
Member Avatar Addgirl48 (61.06) Submitted: 3/29/2008 11:21:19 AM : Outperform Start Price: $1.58 ENZN Score: -89.04

People all ways needing pills so Pharmaceuticals all ways geting business and all ways will

Recs

0
Member Avatar djinsanity (< 20) Submitted: 2/9/2008 12:17:36 PM : Outperform Start Price: $1.38 ENZN Score: -78.85

PEG-SN38 showed anti-tumor activity in resistant pre-clinical models, FDA approval for DepoCyt, leader in stem cell research, I can see it doing phenomenal

Recs

0
Member Avatar henncoop (77.49) Submitted: 3/7/2007 11:04:59 AM : Outperform Start Price: $1.40 ENZN Score: -75.41

low PE &amp; a good choice for a play in this sector

Recs

0
Member Avatar pbqstraining (< 20) Submitted: 1/12/2007 10:52:34 PM : Outperform Start Price: $1.46 ENZN Score: -74.46

NICE PIPELINE

Recs

0
Member Avatar j3nzsrfs (< 20) Submitted: 11/25/2006 10:29:17 PM : Outperform Start Price: $1.42 ENZN Score: -75.66

New cancer treatment

Recs

0
Member Avatar MadisonClub1 (< 20) Submitted: 11/22/2006 8:11:36 PM : Outperform Start Price: $1.42 ENZN Score: -75.62

All looks bad for it but ....just a feeling

Results 1 - 16 of 16

Featured Broker Partners